Prognostic value of serum S100 protein by elecsys S100 immunoassay in patients with spontaneous subarachnoid and intracerebral hemorrhages

Journal of Korean Neurosurgical Society

Volumn 44, Issue 5, 2008, Pages 308-313

  Yoon, Seok Mann ^a   Choi, Young Jin ^b   Kim, Hwi Jun ^b   Shim, Jai Joon ^a   Bae, Hack Gun ^a   Yun, Il Gyu ^a  

^a Department of Internal Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Elecsys S100 immunoassay; Intracerebral hemorrhage; Prognosis; S100 protein; Subarachnoid hemorrhage

Indexed keywords

MANNITOL; NIMODIPINE; PROTEIN S 100;

ADULT; ANEURYSM RUPTURE; ANEURYSM SURGERY; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ARTERY ANEURYSM; BRAIN DAMAGE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLIP; CONTROLLED STUDY; CRANIOTOMY; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HEMATOMA; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE;

EID: 63249091075     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2008.44.5.308     Document Type: Article

References (23)

1. Alber B, Hein R, Garbe C, Caroli U, Luppa PB: Multicenter evaluation of the analytical and clinical performance of the Elecsys S100 immunoassay in patients with malignant melanoma. Clin Chem Lab Med 43: 557-563, 2005
2. Blomquist S, Johnsson P, Lührs C, Malmkvist G, Solem JO, Alling C, et al: The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. J Cardiothorac Vasc Anesth 11: 699-703, 1997
3. Butterworth RJ, Sherwood RA, Bath PM: Serum S-100 protein in acute stroke. Stroke 29: 730, 1998
4. Buttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W: S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 28: 1961-1965, 1997
5. Delgado P, Alvarez Sabin J, Santamarina E, Molina CA, Quintana M, Rosell A, et al: Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke 37: 2837-2839, 2006
6. Foerch C, Singer OC, Neumann-Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M: Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 62: 1130-1134, 2005
7. Gebel JM, Sila CA, Sloan MA, Granger CB, Weisenberger JP, Green CL, et al: Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial. Stroke 29: 1799-1801, 1998
8. Haimoto H, Hosoda S, Kato K: Differential distribution of immunoreactive S-100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest 57: 489-498, 1987
9. Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, et al: Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry 70: 95-100, 2001
10. Kahn HJ, Baumal R, Van Eldik LJ, Dunn RJ, Marks A: Immunoreactivity of S100 beta in heart, skeletal muscle, and kidney in Chronic lung disease: possible induction by cAMP. Mod Pathol 4: 698-701, 1991
11. Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, et al: Serum S-100 beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97: 2806-2813, 2003
12. Korfias S, Stranjalis G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis A, et al: Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem 13: 3719-3731, 2006
13. Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28: 1956-1960, 1997
14. Moore BW: A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19: 739-744, 1965
15. Muller K, Elverland A, Romner B, Waterloo K, Langbakk B, Unden J, et al: Analysis of protein S-100B in serum: a methodological study. Clin Chem Lab Med 44: 1111-1114, 2006
16. Mussack T, Kirchhoff C, Buhmann S, Biberthaler P, Ladurner R, Gippner-Steppert C, et al: Significance of Elecsys S100 immunoassay for real-time assessment of traumatic brain damage in multiple trauma patients. Clin Chem Lab Med 44: 1140-1145, 2006
17. Oertel M, Schumacher U, McArthur DL, Kasmer S, Boker DK: S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. J Clin Neurosci 13: 834-840, 2006
18. Oh EJ, Kim YM, Jegal DW, Kahng J, Park YJ, Han K: Diagnostic value of Elecsys S100 as a marker of acute brain injury in the emergency department. J Clin Lab Anal 21: 387-392, 2007
19. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V: Serum S-100B protein in severe head injury. Neurosurgery 45: 477-483, 1999
20. Smit LH, Korse CM, Bonfrer JM: Comparison of four different assays for determination of serum S-100B. Int J Biol Markers 20: 34-42, 2005
21. Stranjalis G, Korfias S, Psachoulia C, Kouyialis A, Sakas DE, Mendelow AD: The prognostic value of serum S-100B protein in spontaneous subarachnoid haemorrhage. Acta Neurochir (Wien) 149: 231-237; discussion 237-238, 2007
22. Weiss N, Sanchez-Pena P, Roche S, Beaudeux JL, Colonne C, Coriat P, et al: Prognosis value of plasma S-100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology 104: 658-666, 2006
23. Wiesmann M, Missler U, Hagenstrom H, Gottmann D: S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 139: 1155-1160, 1997